Refining Milan criteria: is the alpha-fetoprotein model ready to cross borders?

More than two decades after the adoption of Milan criteria for selection of hepatocellular carcinoma (HCC) patients for liver transplantation (LT) in the majority of the centers worldwide, several assumptions can be made.